(Q34573761)

3 August 2017

1 reference

title

Cancer and the prothrombotic state (English)

1 reference

3 August 2017

Gregory Y H Lip

1 reference

3 August 2017

Andrew D Blann

1 reference

3 August 2017

Bernard S P Chin

1 reference

3 August 2017

publication date

1 January 2002

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

27-34

1 reference

The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Warfarin is safe as secondary prophylaxis in patients with cancer and a previous episode of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Non-bacterial thrombotic endocarditis: clinicopathologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Deep-vein thrombosis and the incidence of subsequent symptomatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

The incidence of occult cancer in patients with deep venous thrombosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

HUS and TTP: variable expression of a single entity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

The significance of measuring monocyte tissue factor activity in patients with breast and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Tissue factor expression correlates with histological grade in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

The hypercoagulable state in cancer patients: evidence for impaired thrombin inhibitions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Plasma levels of D-dimer: a crosslinked fibrin-degradation product in female breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Prognostic significance of plasma D-dimer levels in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Evaluation of β thromboglobulin levels in cancer patients : Effects of antitumor chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Beta-thromboglobulin and platelet-factor 4 in patients with cancer: Correlation with the stage of disease and the effect of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Diagnostic Value of Fibrinopeptide A and Beta-Thromboglobulin in Acute Deep Venous Thrombosis and Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Thrombosis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Tissue factor expression and angiogenesis in human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Interstitial fluid pressure and capillary diameter distribution in human melanoma xenografts.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Characterization of heterogeneous distribution of tumor blood flow in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Observation of microvascular casts of human hepatocellular carcinoma by scanning electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Altered viscosity and yield stress in patients with abdominal malignancy: relationship to deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

D-dimer and CA 125 levels in patients with ovarian cancer during antineoplastic therapy. Prognostic significance for the success of anti-cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Plasma thrombosis-inducing activity in 120 patients with primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Haemostatic abnormalities and outcome in patients with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Haematological stress syndrome in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Screening for cancer in venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

Surrogate markers of tumoral angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900619-2

7 January 2021

10.1016/S1470-2045(01)00619-2

Identifiers

DOI

1 reference

3 August 2017

1 reference